Clarity Pharmaceuticals Ltd News

S&P DJI Announces December 2024 Quarterly Rebalance

Dec 6 01:08 ET

Clarity Pharmaceuticals Ltd: Cleansing Notice

Dec 5 16:57 ET

Clarity Pharmaceuticals Ltd: Application for quotation of securities - CU6

Dec 5 16:56 ET

Clarity Pharmaceuticals Ltd: Last patient assessment completed for SARTATE trial

Nov 27 17:57 ET

Clarity Pharmaceuticals Ltd: First 2 participants dosed with Cu-64 SAR-bisPSMA in Co-PSMA

Nov 25 17:56 ET

Clarity Pharmaceuticals Ltd: Change of Director's Interests - All Directors

Nov 25 17:31 ET

Clarity Pharmaceuticals Ltd: Notification regarding unquoted securities - CU6

Nov 24 22:34 ET

Clarity Pharmaceuticals Ltd: Results of Meeting

Nov 19 21:27 ET

Clarity Pharmaceuticals Ltd: Chairperson Address AGM

Nov 19 17:27 ET

Clarity Pharmaceuticals Ltd: AGM MD Presentation

Nov 19 17:25 ET

Clarity Pharmaceuticals Ltd: Head-to-head IIT with SAR-bisPSMA

Nov 17 17:36 ET

Clarity Pharmaceuticals Ltd: Clarity and Nucleus RadioPharma sign MSA

Nov 10 17:37 ET

Clarity Pharmaceuticals Ltd: CMS final rule on radio-diagnostic reimbursement policy

Nov 4 17:50 ET

Clarity Pharmaceuticals Ltd: Notification regarding unquoted securities - CU6

Oct 31 19:41 ET

Clarity Pharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 30 23:18 ET

Clarity Pharmaceuticals Ltd: Cleansing Notice

Oct 27 23:34 ET

Clarity Pharmaceuticals Ltd: Application for quotation of securities - CU6

Oct 27 23:32 ET

Clarity Pharmaceuticals Ltd: Notice of Annual General Meeting/Proxy Form

Oct 17 19:50 ET

Clarity Pharmaceuticals Ltd: Cleansing Notice

Oct 16 18:55 ET

Clarity Pharmaceuticals Ltd: Application for quotation of securities - CU6

Oct 16 18:50 ET